. A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011 Apr 19;76(16):1389-94. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

This paper appears in the following:

Webinars

  1. Volunteers Help Scientists Explore Down’s, Alzheimer’s Nexus